On the edge. Proven. Reliable

MediosHI
ROP AI

The World’s First Truly Offline AI Solution for Screening and Clinical Documentation of Retinopathy of Prematurity (ROP).

Serves a

USD

212.6 Million

Growing at a CAGR of 19.3%

AI-Autograding ROP (Retinopathy of Prematurity) Market.

MediosHI ROP AI serves neonatal intensive care units (NICUs), paediatric hospitals, and public health screening programs focused on early detection and timely management of ROP in preterm infants

^#sources

Bringing Timely ROP
Screening to the Point of Care.

~1.4 million preterm infants are at risk of ROP each year. A leading cause of preventable childhood blindness, ROP demands timely screening, yet limited specialist access and inconsistent NICU workflows result in delayed or missed diagnoses.

MediosHI ROP AI closes this gap by enabling consistent, objective analysis of retinal images, supporting early identification of at-risk infants, timely referral, and reliable adherence to ROP screening protocols at scale.

Download brochure

Product Features

Clinically Validated Performance: MediosHI ROP AI models for ROP screening have demonstrated high accuracy in published studies, with average sensitivity ~96 % and specificity ~98 % for detecting ROP.

On‑the‑Edge AI Analysis: Performs fully offline, on‑device retinal images, highlighting clinically relevant features and supporting consistent, objective screening.

Point-of-Care ROP Screening: Provides fast, reliable bedside results for timely decisions and referrals. Supports high-volume, standardized screening across all NICUs and large programs, maintaining consistent clinical quality.

Smart Solutions Tailored
for Every Setting

Neonatal Intensive
Care Units (NICUs)

Maternity
Centres

Public Health & Government
ROP Programs

Tertiary Eye Care Centers
& Referral Networks

Private Eye
Clinics

Specialty Screening
Centers

Clinical Validation & Device Performance

Development and validation of an artificial intelligence based screening tool for detection of retinopathy of prematurity in a South Indian population

View Publication

Seamless patient data management and
real-time tele-diagnosis

Remidio Connect lets you securely access patient records and retinal images in just a few clicks, with near real-time image review and live viewing for faster clinical decisions

Handheld, Non-Mydriatic
Fundus Camera

The FOP-NM Handheld Fundus Camera captures high-quality, wide-field retinal images in non-mydriatic mode no drops, no high-intensity flash.

Edge AI based screening platforms for diabetic retinopathy, glaucoma, and age-related macular degeneration provide immediate decision support in settings without on-site ophthalmologists.

Learn More

Portable Digital Slit
‍Lamp on the go

The PSL Portable Digital Slit Lamp provides crystal-clear stills and video of the anterior eye. Adjustable slit width and angle, plus multiple illumination modes make it easy to highlight key details.

Learn More

Handheld Auto
Refractometer

The InstaRef R20 delivers objective refraction in seconds using Shack-Hartmann wavefront technology. Auto-alignment and auto-capture make operation simple, even for non-specialists.

Learn More

Remidio Connect
Cloud Platform

Accessall your patient data captured by all devices stored securely inour cloud database.
‍
Interoperable with EMR systems, PACS & other third-party software.

Remidio is ISO-27001 certified and data is secured using enterprise grade security practices.

Learn More

MediosHI
ROP AI

USD

212.6

Million

Growing at a CAGR of 19.3%

AI-Autograding ROP (Retinopathy of Prematurity) Market.

Bringing Timely ROP
Screening to the Point of Care.

Product Features

Seamless Telemedicine
Experience An Eye Clinic

Smart Solutions Tailored
for Every Setting

Home visits and
elderly care

Corporate and executive
health programs

Assisted living and
nursing homes

Satellite clinics and
outreach units

VIP lounges and
premium services

Post-op and chronic
follow-ups closer to home